Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells

Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking targeted therapy currently. Recent studies imply that protein kinase C may play important roles in TNBC development and could be a specific target. In this study, we evaluated the anti-proliferative activity of PKC inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wanjun, Huang, Jiajun, Yuan, Zhongwen, Feng, Senling, Xie, Ying, Ma, Wenzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435721/
https://www.ncbi.nlm.nih.gov/pubmed/28515445
http://dx.doi.org/10.1038/s41598-017-02222-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435721/
https://www.ncbi.nlm.nih.gov/pubmed/28515445
http://dx.doi.org/10.1038/s41598-017-02222-0

Ejemplares similares